Industry's favored flu shot production process hurt efficacy last year: study

Industry's favored flu shot production process hurt efficacy last year: study

Seqirus has a cell-based flu vaccine manufacturing plant in North Carolina.

Vaccine producers have made flu shots with eggs for decades, but a new study says the manufacturing process curbed the efficacy of last year's shot and warns that the problem could repeat this year.